Mersana Therapeutics, Inc.·4

Jan 25, 4:07 PM ET

Jack Eva M. 4

4 · Mersana Therapeutics, Inc. · Filed Jan 25, 2019

Insider Transaction Report

Form 4
Period: 2019-01-23
Jack Eva M.
CBO, Treasurer & Secretary
Transactions
  • Award

    Stock Option (right to buy)

    2019-01-23+60,00060,000 total
    Exercise: $3.51Exp: 2029-01-23Common Stock (60,000 underlying)
Footnotes (1)
  • [F1]The options vest in equal quarterly installments over the first four years after the vesting commencement date, January 23, 2019.

Documents

1 file
  • 4
    a4.xmlPrimary

    4